imipramine has been researched along with Cancer of Larynx in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murphy, GE | 1 |
Ogura, J | 1 |
Molnár, J | 1 |
Mucsi, I | 1 |
Kása, P | 1 |
2 other studies available for imipramine and Cancer of Larynx
Article | Year |
---|---|
Rehabilitation following laryngectomy.
Topics: Amitriptyline; Depression; Electroconvulsive Therapy; Humans; Imipramine; Laryngeal Neoplasms; Laryn | 1967 |
Inhibition of the adhesion of E. coli on cultured human epithelial cells in the presence of promethazine or imipramine.
Topics: Adhesiveness; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epithelium; Escherichia coli; Fimb | 1983 |